Immunization of guinea pigs with thyroglobulin resulted in the production of antisera which bound 1251-insulin, and this binding was inhibited by iodinated peptides, MIT and DIT, but not by unlabelled insulin.
Binding of 125I-insulin by sera of thyroiditis patients was not clearly demonstrated by gel filtration or paper hydrodynamic flow methods, suggesting the weakness of the binding. These findings suggest that serum 125I-insulin binding in Hashimoto's thyroiditis is not due to insulin antibody but due to some other factor, possibly to anti-thyroglobulin antibody with binding specificity to iodotyrosine residues. Such a binding could be a pitfall for the detection of hormone antibodies using radioiodinated hormones, as well as a source of error in some radioimmunoassays. Serum of a patient with Graves' disease also bound 125I-insulin but not the other iodinated peptides and the binding was inhibited to some extent both by unlabelled insulin and by iodinated compounds. The nature of this binding remains obscure.
Abnormal binding of thyroid hormones to gamma globulins in patients with diseases of thyroid has been reported (Robbins et al., 1956; Premachandra and Blumenthal, 1967; Ochi et al., 1972; Staeheli et al., 1975) . Graves' disease and Hashimoto's thyroiditis are often associated with various forms of autoimmunity (De Groot and Stanbury, 1975; Doniach et al., 1963) . In 1974, Hirata and his collaborators reported a case of Graves' disease accompanied by hypoglycemia, which was presumably caused by insulin autoimmunity.
Screening study by their group revealed that insulin "autoantibodies" occasionally occur in patients with thyrotoxicosis treated with methimazol (Ito et al., 1974) .
We were interested in their reports, and conducted screening of sera of patients with various thyroid diseases by the use of 125Iinsulin and polyethylene glycol precipitation method in search of insulin "autoimmunity". During this screening, we found several sera which bound 125I-insulin more than normal. Three cases with the highest binding were patients with Hashimoto's thyroiditis.
The subsequent study disclosed, however, that this binding was not due to insulin antibody, but suggested that antithyroglobulin antibody in their sera probably cross-reacted with various iodinated peptides.
We also demonstrated that sera of guinea pigs immunized with pork thyroglobulin bound 125I-insulin. These results are reported in this paper.
Materials and Methods

Material s
Polyethylene glycol (mean molecular weight= 7500), and L-thyroxine (T4) were purchased from Wako Pure Chemicals (Tokyo). Diiodotyrosine (DIT) and monoiodotyrosine (MIT) were purchased from Nakarai Chemicals (Kyoto), and 3, 5, 3'-triiodothyronine (T3) from Tokyo Chemical Industry (Tokyo). Radioactive peptides were those prepared for radioimmunoassay. 125I-insulin (specific activity: about 300 mCi/ mg), 125 I-gastrin (= 100mCi/mg), 125 I-GH (=100 mCi/mg), 125I-prolactin (mCi/ mg) and 125I-T3 (= 600 mCi/ mg) were obtained from Dainabot Radioisotope Laboratories (Tokyo). 125 I-C-peptide (= 200 mCi/ mg), 125 I-TSH (=70 mCi/ mg) and 125 I-T4 (= 450 mCi/ mg) were the products of Daiichi Radioisotope Laboratory (Tokyo). 125I-DIT (=430 mCi/mg) and 125I-MIT (=720 mCi/mg) were supplied by Dainabot Laboratory (Tokyo). Hemocyanin was purchased from Calbiochem (La Jolla, Calif.). Titers of antithyroglobulin and anti-microsome antibodies were examined by the Thyroid Test and Microsome Test, both of which were the products of Fuji Zoki Co. (Tokyo). Both tests are based on agglutination reaction of sheep erythrocytes which are tagged either with human thyroglobulin or with microsomes of thyroid glands of Graves' disease patients. Porcine thyroglobulin was a gift of Prof. N. Ui, Gunma University.
Iodination of insulin and bovine serum albumin
Iodinated insulin and bovine serum albumin were prepared by a chloramine T method (Hunter and Greenwood, 1962) . Four mg of pork insulin was dissolved in 0.5ml of 0.01 N HCl, and mixed with 0.1ml of 10mg/ml KI. Next, 0.2ml of 6mg/ml chloramine T, dissolved in 0.5 M phosphate buffer (pH 7.4), was added, stirred for 30 seconds, and then the reaction was stopped by adding 0.2 ml of 6 mg/ml sodium metabisulfite in 0.5 M phosphate buffer (pH 7.4). To a solution of 40mg bovine serum albumin dissolved in 0.5ml water, 0.5ml of 10mg/ml KI and 1ml of chloramine T (6mg/ml) was added and reacted 94 cases examined, 7 sera showed binding ratio higher than 10%, and 4 sera bound more than 15%.
Although some other thyroid patients had slightly higher binding ratios of 125I-insulin than normal, we did not pursue the significance of these differences further.
There was a tendency that samples with the high binding ratio were more often found in sera with very high titers of anti-thyroglobulin and antimicrosome antibodies. The clinical features of 4 cases whose sera had particularly high binding are shown in Table 1 . They all had fairly large goiters. Three of them were diagnosed to have Hashimoto's thyroiditis, one by needle biopsy and two clinically, and were characterized by elevated serum gamma globulin and extremely high titers for anti-thyroglobulin and anti-microsome antibodies. Sera of these 4 patients were studied further.
Binding by serum of various radioiodinated peptides, iodothyronines and iodotyrosines
The binding of various 125I-labelled peptides, iodothyronines and iodotyrosines to serum was tested by means of the polyethylene glycol method. As shown in Table  2 , sera of 3 patients (A, B and C) with Hashimoto's thyroiditis bound greater amounts of 125I_labelled insulin, 125I-C-peptide, 125Igastrin, 125I-GH, 125I-prolactin and 125I-TSH than normal. The serum of case D (Graves' disease) bound more 125I-insulin than normal, but the binding of other peptides was nearly normal or only marginally increased. The serum of an insulin-treated diabetic patient bound only 125I-insulin. Binding ratios of iodinated peptides by two sera with hypergammaglobulinemia were little increased or normal.
There was no significant binding of 125I-T3 by any of sera examined. The sera of two patients (A, B) bound a slightly greater amount of 125I-MIT . The binding of 125I-DIT differed little among different sera. The test for 125I -T4 binding was performed in only two cases, resulting in similar values.
Effects of additions of various substances on binding of 125I-insulin and other 125Ilabelled peptides to serum
As shown in Table 3 , the binding of 125Iinsulin by sera of Hashimoto's thyroiditis was not competitively inhibited, but even rather slightly increased by the addition of a large amout of unlabelled pork insulin. It was decreased by the addition of thyroglobulin, iodinated insulin, iodinated bovine albumin, MIT and DIT, and to a lesser extent by T3 and T4. The serum of case C was studied in somewhat more detail on a different occasion. The addition of human plasma or human plasma protein fractions (data not shown), hemocyanin and bovine glycol method, other two methods failed to show significant binding of 125I-insulin to these sera. As shown in Table 4 , the percentages of bound to total 125I-insulin were 5.2-9.7% by the gel filtration method and 7.8-10.1 % by the hydrodynamic flow technique on a filter paper. These binding ratios were much smaller than the corresponding values obtained by the polyethylene glycol method for aliquots of the same incubation mixtures. In contrast, high binding ratios of similar magnitude were obtained by each of these three methods for a serum from an insulin-treated diabetic patient.
Binding of 125I-insulin, labelled T3 and T4 by guinea pig anti-thyroglobulin serum Three guinea pig antisera immunized with pork thyroglobulin all bound 125Iinsulin significantly more than the control guinea pig serum by the polyethylene glycol method (Table 5 ). This binding was not inhibited by the addition of unlabelled insulin, but was inhibited by iodinated insulin, iodinated bovine albumin, thyroglobulin, MIT and DIT, and to a lesser extent by T3 and T4. These antisera also bound 125I-T3 and 125I-T4. The binding of labelled T3 and T4 was not inhibited by iodinated bovine albumin. 125I-T3 binding by antiserum III was decreased by the 
Discussion
It has been reported that serum immunoglobulin of some patients with autoimmune thyroiditis or other thyroid diseases binds T3 and/or T4 (Robbins et al., 1956; Premachandra and Blumenthal, 1967; Ochi et al., 1972; Staeheli et al., 1975) . This abnormal binding is, in general, more commonly observed in patients with higher titers of anti-thyroglobulin antibody, although Wu and Green (1976) reported a case of T3specific binding without elevated titers of antibodies to thyroglobulin or thyroid microsomes. The binding of T3 and T4 by immunoglobulin can be produced also in experimental animals, by actively immunizing them with thyroglobulin or denatured thyroglobulin (Chopra et al., 1971; Ochi et al., 1972) . The specificity of binding apparently differs with different sera, but the binding of thyronine derivatives is usually stronger than that of iodotyrosines. In a study of hapten inhibition of antithyroglobulin precipitation reaction, Margherita and Premachandra (1967) found inhibition by DIT in only 2 animals among 15 rabbits which were immunized with thyroglobulin.
We found the significantly higher binding Endocrinol. Japon. December 1978 of 125I-insulin to serum in several patients with thyroid diseases by means of polyethylene glycol precipitation.
At first, we considered that this binding might be due to "insulin auto-antibodies" such as reported by Hirata et al. in patients with Graves' disease (Hirata et al., 1974; Ito et al., 1974) . Our more detailed study revealed, however, that this binding was not directed to insulin molecule itself in patients with Hashimoto's thyroiditis.
Unlike the case of Hirata et al.(1974) , the binding of 125 Iinsulin by these sera (cases A, B and C) was not competitively inhibited by the addition of unlabelled insulin, but suppressed by various iodinated peptides and proteins and thyroglobulin, as well as by MIT and DIT and to some extent by T3 and T4. These sera bound virtually all the iodinated peptides tested by our hands significantly more than normal sera. The binding of 125 I-GH and 125I-TSH was also not inhibited by the corresponding unlabelled hormones but by iodinated bovine albumin and DIT. These features are entirely different from those of serum containing specific insulin-antibody, the binding of which is effectively suppressed by insulin but not by other iodinated compounds.
Our 3 cases of Hashimoto's thyroiditis all had elevated levels of serum gamma globulins.
Therefore, we considered the possibility that the increased amount of precipitates by polyethylene glycol might have resulted in a greater coprecipitation of radioactivity. The sera of two patients with similar degree of hypergammaglobulinemia were associated with a slight increase in precipitated radioactivity, but the degree of increase was far less in comparison with the sera of the above Hashimoto's thyroiditis patients.
The inhibition of '25I-insulin binding by the addition of iodinated compounds occurred without the decrease in the amount of precipitates.
Therefore, the increase in 125 I-labelled peptide binding does not seem to be a non-specific coprecipitation of radioactivity accompanying the increase in precipitates.
The serum of one patient with Graves' disease (case D) also bound 125 I-insulin significantly, but the nature of this binding appears to be different from that of Hashimoto's thyroiditis. This serum did not bind other iodinated peptides and the binding of 125I -insulin was suppressed slightly or moderately both by unlabelled insulin and iodinated compounds.
There might be heterogenous binding factors or the binding may involve iodotyrosines plus some part of insulin molecule, but we could not analyze the nature of this serum in more detail.
The binding of various iodopeptides seems to be best explained assuming that a component of anti-thyroglobulin antibodies in Hashimoto's thyroiditis has a binding specificity against portions including iodotyrosine residues in the thyroglobulin molecule, and it also cross-reacts with iodotyrosine residues of other iodinated peptides. First, the binding of 125 I-insulin was suppressed by thyroglobulin.
Second, antisera with similar binding properties could be produced in guinea pigs by immunization with porcine thyroglobulin.
Third, sera showing significant iodopeptide binding all had extremely high titers of anti-thyroglobulin.
The properties of guinea pig antisera were similar to the sera of Hashimoto's thyroiditis patients in the fact that they bound 125 I-insulin and the binding was suppressed by thyroglobulin, iodinated insulin and iodotyrosines but not by unlabelled insulin. There was a difference, however, in the fact that guinea pig antisera bound radioactive T3 and T4 much more than the sera of these patients. The binding of labelled T3 and T4 by one guinea pig serum was inhibited by unlabelled T3 and T4 but not by MIT and DIT, whereas the binding of 125I-insulin was suppressed by MIT and DIT more strongly than by T3 and T4, suggesting the Vol. 25, No. 6 ABNOfiRMAL BINDING OF IODOPEPTIDES presence of two types of antibodies with different specificities in this serum. Presumably, the sera of Hashimoto's thyroiditis patients investigated here contained only the types of antibody of the latter specificity.
The existence of these two types of specificities may suggest that alpha-benzene ring of thyronine structure is involved in determining the specificities of antigenic sites of thyroglobulin.
The binding of 125I-MIT by these sera was not so marked; however, the binding of '25I-DIT was insignificant.
There may be some differences in conformation or reactivity between iodotyrosine residues in peptide chains and free iodotyrosines.
The inhibition of 125I-insulin binding by sera of Hashimoto's thyroiditis was incomplete even by the addition of high concentration of iodinated compounds.
One mg/ml of iodinated insulin did not increase the inhibition further than that achieved by 0.1mg/ml. The nature of this remaining binding is unexplained at present. In contrast to the results obtained by the polyethylene glycol method, the binding of 125I-insulin was not so clearly demonstrated by other methods separating bound and free 125I-insulin.
The cause of this disagreement by different methods is not clear, but we presume that the binding of 125I -insulin to the "antibody" is so weak as to permit easy dissociation simply by dilution of the reaction mixture or by a stronger adsorption to other substance such as filter paper.
The dissociation of bound method may have obscured the binding, whereas the virtually instantaneous precipitation of beta and gamma globulins by polyethylene glycol (Polson et al., 1964) enabled to demonstrate the binding. This report describes the possibility that human sera with high antithyroglobulin titers may form a weak binding to many iodinated peptides, probably involving their iodotyrosine residues. The binding of this sort can be a pitfall for the detection of hormone antibodies using radioiodinated hormones as tracer.
Namely, iodinated hormones may sometimes behave unlike unlabelled ones. The effects of abnormal binding of thyroid hormones on radioimmunoassay of T3 and T4 have been discussed (Desbuquois and Aurbach, 1971) . Although these points have not been investigated in detail in our cases, TSH, T3, T4 and insulin values of these sera by routine immunoassay fell within fairly reasonable ranges. The weakness of binding may not have interfered so much with the true antigenantibody reactions of stronger affinity in the radioimmunoassay.
It is possible, however, that the binding may give false assay values of hormones in blood, in some circumstances in which the cross-reaction involves a stronger binding.
